MEDPLUS

Medplus Health Services Limited

MedPlus Health Services Limited has submitted newspaper clippings of un-audited standalone and consolidated financial results for the quarter ended June 30, 2026, as per Regulation 33 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Medplus Health Services Limited

MedPlus Health Services Limited has informed that its subsidiary, Optival Health Solutions Private Limited, has received three suspension orders for drug licenses of stores in Karnataka, resulting in potential revenue loss of Rs 0.49 lacs, Rs 0.12 lacs, and Rs 0.42 lacs for two and one days respectively.

Medplus Health Services Limited

Medplus Health Services Limited has announced its Q1 FY2027 investor presentation, highlighting its 20-year presence, 5,450+ stores across 13 states, and 30k+ employees. The company reported a revenue of ₹18,796m, a gross margin of 24.5%, and an operating EBITDA of ₹1,898m. The company added 222 stores in Q1 FY2027, with 125 net additions beyond Tier-One, and achieved a store level EBITDA margin of 10.4% and operating ROCE of 63.0%.

Medplus Health Services Limited

Medplus Health Services Limited has announced its Q1 FY27 results, with revenue growing 21.8% YoY and 0.8% QoQ, but gross margin decreasing by 160 bps YoY and 200 bps QoQ. Operating EBITDA margin decreased by 120 bps YoY and 230 bps QoQ. The company added 146 new stores, including 131 new franchisees, during the quarter.

Medplus Health Services Limited

Medplus Health Services Limited has announced the appointment of Mr. Shrenik Soni as the Company Secretary and Compliance Officer, effective July 21, 2026.

Medplus Health Services Limited

Medplus Health Services Limited has announced the outcome of its board meeting, where it approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with a limited review report. The company also approved CAPEX plans for setting up a food park and a concierge health and wellness services facility, and appointed a new company secretary and compliance officer.

Medplus Health Services Limited

MedPlus Health Services Limited has received a suspension order for a Drug License of a store situated in Karnataka due to a two-day suspension under Rule 65 of the Drugs and Cosmetics Act, 1940, resulting in a potential revenue loss of Rs 0.53 lacs.

Medplus Health Services Limited

MedPlus Health Services Limited has announced earnings calls for the quarter ended June 30, 2026, as per SEBI regulations.

Medplus Health Services Limited

MedPlus Health Services Limited has received three suspension orders for drug licenses of its subsidiary Optival Health Solutions Private Limited in the state of Karnataka, resulting in potential revenue loss of Rs 0.77 lacs, Rs 0.35 lacs, and Rs 0.47 lacs respectively.

Medplus Health Services Limited

MedPlus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, has received a suspension order for a drug license of a store in Maharashtra, which may impact revenue.

Medplus Health Services Limited

Medplus Health Services Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026, stating that the details of securities dematerialized/rematerialized have been furnished to all the stock exchanges where the shares are listed.

Medplus Health Services Limited

Medplus Health Services Limited has informed the Exchange about General Updates, specifically a suspension order for a Drug License of a store situated in the state of Bangalore, resulting in a potential revenue loss of Rs 5.13 lacs.

Medplus Health Services Limited

MedPlus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, has received a two-day suspension order for a drug license for a store in Karnataka, resulting in a potential revenue loss of Rs 0.80 lacs.

Medplus Health Services Limited

MedPlus Health Services Limited has informed that its subsidiary Optival Health Solutions Private Limited has received two suspension orders for a Drug License of a store situated in the state of Karnataka, resulting in potential revenue loss of Rs 0.32 lacs and Rs 0.47 lacs.

Medplus Health Services Limited

MedPlus Health Services Limited has received three suspension orders for a Drug License of its subsidiary Optival Health Solutions Private Limited, resulting in a potential revenue loss of Rs 0.22 lacs, Rs 0.60 lacs, and Rs 0.76 lacs for one, two, and three days respectively.

Medplus Health Services Limited

MedPlus Health Services Limited has received a one-day suspension order for a drug license of a store in Karnataka due to a violation of the Drugs and Cosmetics Act, resulting in a potential revenue loss of Rs 0.46 lacs.

Medplus Health Services Limited

Medplus Health Services Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Medplus Health Services Limited

MedPlus Health Services Limited has received two suspension orders for a Drug License of a store situated in the state of Andra Pradesh. The suspension is for seven days and may impact the company's revenue by Rs 1.92 lacs and Rs 1.00 lacs respectively.

MEDPLUS

MedPlus Health Services Limited announced that its subsidiary, Optival Health Solutions Private Limited, has received a suspension order for a Drug License. This order pertains to one of its stores located in the state of Maharashtra. The suspension means the affected store cannot operate, representing an operational disruption for the subsidiary. This update was provided to the exchanges under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

MEDPLUS

MedPlus Health Services Limited announced a regulatory update regarding its subsidiary, Optival Health Solutions Private Limited. The subsidiary has received a suspension order for the Drug License of one of its stores. This specific store is located in the state of Telangana. For investors, this indicates a minor operational disruption due to a regulatory action affecting a single retail outlet within the company's wider network.